0001865165-21-000003.txt : 20210629 0001865165-21-000003.hdr.sgml : 20210629 20210629110600 ACCESSION NUMBER: 0001865165-21-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210629 DATE AS OF CHANGE: 20210629 EFFECTIVENESS DATE: 20210629 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synaptogenix, Inc. CENTRAL INDEX KEY: 0001571934 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461585656 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-404539 FILM NUMBER: 211056343 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 9732420005 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: NEUROTROPE BIOSCIENCE, INC. DATE OF NAME CHANGE: 20130312 D 1 primary_doc.xml X0708 D LIVE 0001571934 Synaptogenix, Inc. 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY NEW YORK 10036 973-242-0005 DELAWARE NEUROTROPE BIOSCIENCE, INC. Corporation true Alan J. Tuchman c/o Synaptogenix, Inc. 1185 Avenue of the Americas, 3rd Floor New York NY NEW YORK 10036 Executive Officer Director Robert Weinstein c/o Synaptogenix, Inc. 1185 Avenue of the Americas, 3rd Floor New York NY NEW YORK 10036 Executive Officer Daniel A. Alkon c/o Synaptogenix, Inc. 1185 Avenue of the Americas, 3rd Floor New York NY NEW YORK 10036 Executive Officer Director Joshua N. Silverman c/o Synaptogenix, Inc. 1185 Avenue of the Americas, 3rd Floor New York NY NEW YORK 10036 Director William Singer c/o Synaptogenix, Inc. 1185 Avenue of the Americas, 3rd Floor New York NY NEW YORK 10036 Director Bruce T. Bernstein c/o Synaptogenix, Inc. 1185 Avenue of the Americas, 3rd Floor New York NY NEW YORK 10036 Director George Perry c/o Synaptogenix, Inc. 1185 Avenue of the Americas, 3rd Floor New York NY NEW YORK 10036 Director Jonathan L. Schechter c/o Synaptogenix, Inc. 1185 Avenue of the Americas, 3rd Floor New York NY NEW YORK 10036 Director Biotechnology Decline to Disclose 06b false 2021-06-14 false true true false 0 Katalyst Securities LLC 112494 None None 655 Third Avenue, 18th Floor New York NY NEW YORK 10017 IL ILLINOIS MD MARYLAND NY NEW YORK false 12477342 12477342 0 false 14 1149997 0 The Issuer also issued Katalyst warrants to purchase 152,378 shares of Issuer's common stock, exercisable for a term of five years at an exercise price of $8.51 per share. 0 false Synaptogenix, Inc. /s/ Robert Weinstein Robert Weinstein Chief Financial Officer 2021-06-28